52
Telomir closes $5.6M PIPE financing at $1.16/share
Why it matters
Telomir completed a private placement of 4.8M shares at $1.16/share (5% discount to 10-day VWAP), raising $5.6M gross proceeds before expenses. The company will use funds for clinical development of Telomir-Zn in breast cancer trials and working capital, with existing shareholder John Paul DeJoria investing an additional $1M alongside other investors and new participants.
In plain language
A biotech company raised $5.6 million by selling new shares to investors at a slight discount. The money will fund drug development and operations.
Exposure
TELO ·
Price check
not measured: no fresh price at the time of scoringHow this is measured
Information only. AURA does not give buy or sell recommendations.